"During the first quarter of our fiscal year 2027, we delivered another strong set of results. 7% revenue growth on a core constant currency basis on the top line, 50 basis points of year-over-year ...
<?xml encoding="utf-8" ?> ResMed RMD reported first-quarter financial results on Thursday. The transcript from the company’s ...
21:58 ResMed eleva su beneficio ajustado y sus ingresos en el primer trimestre fiscal MT 21:20 Flash de resultados (RMD): ...
ResMed Inc. hat seine Ergebnisse für das erste Quartal zum 30. September 2026 veröffentlicht. Im ersten Quartal erzielte das ...
ResMed Inc. heeft de resultaten over het eerste kwartaal eindigend op 30 september 2026 bekendgemaakt. In het eerste kwartaal ...
ResMed ha registrato utili per azione non-GAAP pari a 2,91 USD nel primo trimestre dell'esercizio, rispetto ai 2,55 USD dello ...
ResMed Inc. ha comunicato i risultati degli utili del primo trimestre chiuso il 30 settembre 2026. Nel primo trimestre, il fatturato della società è stato pari a 1.414,81 Mio USD, rispetto ...
ResMed, Inc. se especializa en el diseño, la fabricación y la comercialización de productos para el diagnóstico, el ...
Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2026. “We began fiscal year 2027 with a strong first quarter, driven by continued global demand for our ...
ResMed reported first-quarter fiscal 2027 results with revenue of $1.4 billion, up 6% year-over-year and 7% on a core constant currency ...
Resmed Inc. Reports Q1 Revenue $1.41B, vs. FactSet Est of $1.39B MT 04:19pm Earnings Flash (RMD) Resmed Inc. Posts Q1 Adjusted EPS $2.91 per Share, vs. FactSet Est of $2.69 MT 02:19pm Drowsy Digital, ...
SAN DIEGO – Resmed reported revenue increased 6% to $1.4 billion in the first quarter of fiscal year 2027. On a core constant currency basis, Americas Sleep and Breathing Health revenue grew 7%, Rest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results